deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT02603965

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men Undergoing Radical Prostatectomy

Sponsor: National Institutes of Health (NIH)

Conditions Prostate Adenocarcinoma Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer
Interventions Computed Tomography Copper Cu 64 TP3805 Laboratory Biomarker Analysis Positron Emission Tomography Radical Prostatectomy
Updated 8 times since 2017 Last updated: May 1, 2025 Started: Aug 31, 2013 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Prostate Adenocarcinoma and Stage IIB Prostate Cancer, this trial is completed. The trial is conducted by National Institutes of Health (NIH) and has accumulated 8 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – ~Feb 2026 · 8 months · monthly snapshotCompleted~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE1

  2. Jun 2025 — Feb 2026 [monthly]

    Completed PHASE1

  3. Sep 2024 — Jun 2025 [monthly]

    Completed PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institutes of Health (NIH)
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations